NUVECTIS PHARMA INC (NVCT) Forecast, Price Target & Analyst Ratings

NASDAQ:NVCT • US67080T1088

Current stock price

7.81 USD
+0.08 (+1.03%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUVECTIS PHARMA INC (NVCT).

Forecast Snapshot

Consensus Price Target

Price Target
$18.56
+ 137.70% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.32
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$18.56
Upside
+ 137.70%
From current price of $7.81 to mean target of $18.56, Based on 12 analyst forecasts
Low
$10.10
Median
$19.38
High
$26.25

Price Target Revisions

1 Month
-0.73%
3 Months
0.18%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for NVCT. The average price target is 18.56 USD. This implies a price increase of 137.7% is expected in the next year compared to the current price of 7.81.
The average price target has been revised upward by 0.18% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NVCT Current Analyst RatingNVCT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

NVCT Historical Analyst RatingsNVCT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
NVCT was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NVCT.
In the previous month the buy percentage consensus was at a similar level.
NVCT was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-04HC Wainwright & Co.Maintains Buy -> Buy
2025-04-30HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-02Maxim GroupInitiate Buy
2025-03-17Laidlaw & Co.Initiate Buy
2025-02-25HC Wainwright & Co.Maintains Buy -> Buy
2024-08-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-08HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-07HC Wainwright & Co.Reiterate Buy
2023-02-10HC Wainwright & Co.Reiterate Buy
2022-07-13Ladenburg ThalmannInitiate Buy
2022-05-10HC Wainwright & Co.Maintains Buy
2022-03-02HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.32
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-17.11%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

NVCT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.32 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
NVCT revenue by date.NVCT revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
NVCT ebitda by date.NVCT ebitda by date.
N/AN/AN/A
-30.28%		N/A
-21.62%		N/A
14.67%		N/A
-45.83%		N/A
-29.64%		N/A
-22.59%		N/A
-26.29%
EBIT
YoY % growth
NVCT ebit by date.NVCT ebit by date.
-10K-12.89M
-128,800.00%		-19.23M
-49.19%		-22.897M
-19.07%		-19.847M
13.32%		-27.574M
-38.93%		N/A
-22.22%		N/A
-16.24%		N/A
7.76%
Operating Margin
NVCT operating margin by date.NVCT operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
NVCT eps by date.NVCT eps by date.
N/AN/AN/A
58.45%		-1.43
0.48%		-1.11
22.38%		-1.21
-9.01%		N/A
-5.16%		N/A
-4.41%		N/A
18.81%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.32
-17.11%		-0.32
-7.95%		-0.33
1.09%		-0.32
-2.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-7.956M
-16.42%		-9.18M
-50.00%		-9.69M
-37.68%		-10.2M
-25.00%
EBIT
Q2Q % growth		-7.935M
-42.51%		-8.118M
-23.09%		-8.311M
-6.64%		-8.507M
-11.69%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NVCT Yearly Revenue VS EstimatesNVCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 5M 10M 15M 20M 25M
NVCT Yearly EPS VS EstimatesNVCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
3.49%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-26.97%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NUVECTIS PHARMA INC / NVCT Forecast FAQ

What is the average price target for NUVECTIS PHARMA INC (NVCT) stock?

12 analysts have analysed NVCT and the average price target is 18.56 USD. This implies a price increase of 137.7% is expected in the next year compared to the current price of 7.81.

Can you provide the upcoming earnings date for NUVECTIS PHARMA INC?

NUVECTIS PHARMA INC (NVCT) will report earnings on 2026-05-04.

What are the consensus estimates for NVCT stock next earnings?

The consensus EPS estimate for the next earnings of NUVECTIS PHARMA INC (NVCT) is -0.32 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for NVCT stock?

The number of analysts covering NUVECTIS PHARMA INC (NVCT) is 12.